MediFind
Condition

Arbovirosis

Condition 101

What are the alternative names for Arbovirosis?

  • Arbovirus fever

Top Global Doctors

AS
Elite
Amadou A. Sall
Dakar, DK, SN
XD
Elite
Xavier N. De Lamballerie
FR
Chantal B. Reusken
Elite
Chantal B. Reusken
Rotterdam, NL
RC
Elite
Remi N. Charrel
Marseille, 93, FR
JC
Elite
Jonas Chanasit-Schmidt
NL

Latest Research

Latest Advance
Study
  • Condition: Viral-related rheumatic syndromes
  • Journal: International journal of molecular sciences
  • Treatment Used: Methotrexate
  • Number of Patients: 0
  • Published —
The articles discusses the effectiveness and safety of Methotrexate.
Latest Advance
Study
  • Condition: Yellow Fever (YF) Disease in a Renal Transplant Recipient
  • Journal: Transplant infectious disease : an official journal of the Transplantation Society
  • Treatment Used: Supportive Care
  • Number of Patients: 1
  • Published —
This case report discusses a 50-year-old male recipient who presented wild-type Yellow fever (YF) five years after a deceased donor kidney transplant.
Latest Advance
Study
  • Condition: Atopic Dermatitis
  • Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
  • Treatment Used: Methotrexate and Cyclosporine
  • Number of Patients: 56
  • Published —
This study compared treatment profiles of methotrexate and cyclosporine in daily practice as the first-line immunosuppressive treatment in atopic dermatitis.

Clinical Trials

Clinical Trial
Other
  • Status: Recruiting
  • Study Type: Other
  • Participants: 80
  • Start Date: September 9, 2020
Characterization of Skin Immunity to Aedes Aegypti Saliva in Dengue-Endemic Participants in Cambodia
Clinical Trial
Other
  • Status: Recruiting
  • Participants: 255
  • Start Date: April 8, 2019
Duration of Immunity 10 Years After a Dose-response Study With Yellow Fever Vaccine - Complementary Study
Clinical Trial
Biological
  • Status: Recruiting
  • Study Type: Biological
  • Participants: 28
  • Start Date: October 9, 2018
Phase 1 Time Lagged, Parallel-Group, Randomized, Placebo-Controlled, Single-Blind, Single Ascending Dose Study of Tyzivumab in ZIKV Infected Patients
Clinical Trial
Other
  • Status: Recruiting
  • Study Type: Other
  • Participants: 70
  • Start Date: June 25, 2018
World Mosquito Program Noumea - Human Sample Component